Pharmaceuticals, Biotechnology and Life Sciences
NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) — Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company…
— Single-cell proteomics can elucidate kinase activity in prostate cancer models — — Kinase activity in bone metastases and epithelial…
Session will include a discussion of the treatment landscape for Mantle Cell Lymphoma, including potential role of Zilovertamab, Oncternal’s ROR1…
The TRials with EblasaKimab in Atopic Dermatitis (TREK-AD) study will evaluate the efficacy and safety of ASLAN004, now known as…
– FDA lifts partial clinical hold following agreement on mitigation strategy for differentiation syndrome – – KOMET-001 study to resume…
Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…
New video blog series part of 2022 commitment to increase and broaden communication to investorsWINNIPEG, Manitoba, Jan. 20, 2022 (GLOBE…
Five-year collaboration to provide support for clinical and preclinical efforts as Yingli Pharma expands its U.S. presence with robust oncology…
Dr. Liu will lead real world data (RWD) strategy and growth of global biopharma company partnerships Shusen Liu, M.D., Ph.D.…
Live video webcast presentation on Thursday, January 27th at 3:00 PM ETEDMONTON, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) — Ceapro…